MAPT and Alzheimer disease: To conclude, in this paper, we present evidence that the category of tau PET positivity denoted by signal that is present in both the MTL and neocortex represent an advancing pattern of AD pathobiology that is associated with very high concordant rates of amyloid PET positivity, increased plasma pTau217 concentration, and unambiguous cognitive decline over a prior period of observation.